Quantcast

Latest Rituximab Stories

2012-05-15 05:16:56

(Ivanhoe Newswire) — Although some anecdotal cases and studies report that the drug rituximab can benefit children that are resistant to standard treatment for idiopathic nephrotic syndrome (INS), a recent study unfortunately proves otherwise. INS is a childhood kidney disorder that is thought to be an immune disorder, but the cause is not fully known. Children with the disease excrete large amounts of protein in their urine and have other signs of kidney damage, and there is an...

2012-05-11 12:03:58

Rituximab seems to only help cases that respond to standard therapies Highlights: Children with a particular kidney immune disorder that is unresponsive to standard treatments do not benefit from the immune drug rituximab. Additional studies are needed to fully understand the disease and to develop effective therapies for hard-to-treat cases. The drug rituximab, an antibody that targets the immune system and is often used to treat immune disorders such as lymphoma and arthritis, has...

2012-05-07 14:37:05

A new analysis concludes that rituximab, a drug commonly used to treat blood cancers, leads to treatment responses lasting at least five years in approximately one quarter of patients with low platelet counts and a risk of bleeding due to chronic immune thrombocytopenic purpura (ITP). In study results published online today in Blood, the Journal of the American Society of Hematology (ASH), investigators at Weill Cornell Medical College provide the very first long-term outcome data for...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related